In recent years there has been a growing interest among cancer biologists in cancer
metabolism. This Review summarizes past and recent advances in our understanding of the …

Renal cell carcinoma (RCC) represents 85–95% of kidney cancers and is the most frequent
type of renal cancer in adult patients. It accounts for 3% of all cancer cases and is in 7th …

Increasing long non-coding RNAs (lncRNAs) have been reported to play key roles in the
development and progression of various malignancies. ZNFX1 antisense RNA1 (ZFAS1) …

Clear cell Renal Cell Carcinoma (ccRCC) is the most common and metastatic urological
cancer. Molecular players of ccRCC progression and metastasis are not completely known …

The tumorigenic role and underlying mechanisms of lipid accumulation, commonly observed
in many cancers, remain insufficiently understood. In this study, we identified an AMP …

One-carbon metabolism plays a central role in a broad array of metabolic processes
required for the survival and growth of tumor cells. However, the molecular basis of how one …

Abstract MicroRNA-150-5p (miR-150-5p) has been implicated in tumor initiation and
progression in a variety of cancers. However, its roles in colorectal cancer (CRC) remain …

Clear cell renal cell carcinoma (ccRCC) is a malignancy that exhibits metabolic
reprogramming as a result of genetic mutations. This reprogramming accommodates the …

Growing evidence indicates that clear cell renal cell carcinoma (ccRCC) is a metabolism-
related disease. Changes in fatty acid (FA) and cholesterol metabolism play important roles …

Mitochondrial dysfunction is common in cancer and the mitochondrial electron transport
chain is often affected in carcinogenesis. To date, little is known about the expression of the …